June 21, 2021 by MMR
Catalina, cough cold, O-T-C
Leading Headlines, Supplier News

ST. PETERSBURG, Fla. – Since the Centers for Disease Control and Prevention (CDC) announced on May 13 that people who are fully vaccinated against COVID-19 no longer need to wear face masks in most indoor settings, there has been a strong, subsequent sales uptick for over-the-counter (O-T-C) medicines designed to treat such maladies as colds,
September 14, 2020 by MMR
CARES Act, O-T-C
2020, Issue 09-14-2020, Issues
NEW YORK — The Coronavirus Aid, Relief and Economic Security (CARES) Act, which became law in March, contains a provision that could help many consumers cut their health care costs. The only problem is that most consumers are probably not aware of the provision and what it means. The CARES Act provision allows consumers with
April 9, 2020 by MMR
CARES Act, CHPA, Consumer Healthcare Products Association, O-T-C
Leading Headlines, Supplier News

WASHINGTON — Consumer Healthcare Products Association (CHPA) president and chief executive officer Scott Melville issued the following statement upon final passage of the CARES Act, which includes provisions to update and modernize the regulatory system overseeing most over-the-counter medicines and to restore O-T-C eligibility under tax-preferred HSA and FSA accounts. Scott Melville “During this unprecedented
February 18, 2020 by MMR
FDA, GlaxoSmithKline, NSAID, O-T-C, over-the-counter, U.S. Food and Drug Administration, Voltaren Arthritis Pain, Voltaren Gel
Leading Headlines, Supplier News

WARREN, N.J. — The Food and Drug Administration has approved Voltaren Arthritis Pain as an over-the-counter remedy for arthritis pain, GlaxoSmithKline said Tuesday. With the FDA’s approval, Voltaren Arthritis Pain becomes the first and only prescription strength, nonsteroidal anti-inflammatory (NSAID) topical gel for arthritis pain available O-T-C in the United States. Voltaren Gel, which GSK Consumer
August 1, 2019 by MMR
GlaxoSmithKline, O-T-C, Over-the-counter (O-T-C) medicines, Pfizer Inc.
Leading Headlines, Supplier News

WARREN, N.J. — GlaxoSmithKline said Thursday that it has closed a previously announced joint venture deal with Pfizer Inc. that will combine their respective consumer healthcare businesses. The move will create the world’s largest supplier of over-the-counter medications. The joint venture company will operate as GSK Consumer Healthcare. Pfizer owns a 32% equity stake in
March 18, 2019 by MMR
Consumer Healthcare Products Association (CHPA), IRI, O-T-C, Over-the-counter (O-T-C) medicines, Scott Melville, Value of O-T-C Medicines to the U.S. Healthcare System
Leading Headlines, Retail News, Topics

WASHINGTON — Over-the-counter (O-T-C) medicines save the U.S. health care system nearly $146 billion a year, a new study has found. The report, “Value of O-T-C Medicines to the U.S. Healthcare System,” which was released by the Consumer Healthcare Products Association (CHPA), found that, on average, each dollar spent on O-T-Cs saves the national system